carfentanil has been researched along with Tobacco Use Disorder in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brasic, JR; Cascella, N; Concheiro, M; Contoreggi, C; Heishman, SJ; Huestis, MA; Kuwabara, H; Mackowick, KM; Rousset, O; Taylor, R; Volkow, ND; Wand, G; Willis, W; Wong, DF | 1 |
Domino, EF; Guthrie, S; Heitzeg, MM; Koeppe, RA; Ni, L; Scott, DJ; Zubieta, JK | 1 |
2 other study(ies) available for carfentanil and Tobacco Use Disorder
Article | Year |
---|---|
Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers.
Topics: Adult; Biomarkers; Brain; Carbon Radioisotopes; Female; Fentanyl; Humans; Male; Middle Aged; Nicotine; Nicotinic Agonists; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Opioid, mu; Reward; Self Report; Severity of Illness Index; Smoking; Tobacco Use Disorder; Young Adult | 2014 |
Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Dopamine; Fentanyl; Gyrus Cinguli; Humans; Male; Neural Pathways; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Opioid Peptides; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Receptors, Opioid, mu; Smoking; Synaptic Transmission; Tobacco Use Disorder | 2007 |